What is an eQMS for medical devices?

An electronic Quality Management System—eQMS—is the software infrastructure that medical device companies use to manage the full scope of quality activities required by regulators. That means document control, CAPA management, nonconformance reports, complaint handling, audit management, supplier qualification, and training records. If it touches quality, it lives in the eQMS.

For regulated medical device manufacturers, an eQMS is not optional. FDA's 21 CFR Part 820 and ISO 13485:2016 both require documented quality management systems. The question is not whether you need one—it is whether the one you have actually serves your engineering team, or whether it imposes a parallel documentation burden that slows development down.

What an eQMS manages

The scope of a mature eQMS covers five core domains, each with its own regulatory expectations.

Document control is the foundation. Every procedure, specification, drawing, and work instruction must be version-controlled, reviewed, approved, and accessible to the right people. In a traditional eQMS, documents are managed in isolation from the engineering artifacts that drove them—creating immediate traceability problems.

CAPA management—corrective and preventive action—is where quality meets engineering problem-solving. When a nonconformance is detected, the CAPA process requires root cause analysis, corrective action planning, implementation verification, and effectiveness checks. A weak CAPA process is one of the most common FDA 483 observation categories.

Nonconformance reports (NCRs) capture product or process deviations that occur during manufacturing or testing. Linking NCRs to design records, risk analysis, and related design changes requires cross-referencing across systems that, in most organizations, do not communicate.

Complaint handling is the post-market quality loop—tracking complaints, evaluating whether they constitute MDR-reportable adverse events, and feeding findings back into the CAPA process. The traceability chain from field complaint to design decision is difficult to reconstruct when those decisions live in engineering systems that never touched the eQMS.

Audit management covers internal audits, supplier audits, and preparation for FDA inspections or notified body reviews. Audit readiness means being able to demonstrate—on demand—that your quality system is operating as documented.

Why most eQMS implementations fail engineering teams

Traditional eQMS platforms were designed around quality professionals, not engineers. The result is a system that engineers treat as a documentation obligation—somewhere to file things after the real work is done. This creates a structural gap: the engineering decisions that drive quality outcomes are made in CAD tools, requirements management systems, and version control—then manually transcribed into the eQMS.

That transcription step is where errors propagate, traceability breaks, and regulatory exposure accumulates. When a design change happens—a material substitution, a firmware update, a dimensional tolerance shift—someone must manually determine which quality records need updating, which risk assessments are affected, and which CAPAs are now in scope. That determination requires engineering judgment, but the systems that hold the engineering data and the systems that hold the quality data are separate.

The downstream consequence is significant. During an FDA inspection or notified body audit, reviewers will trace design decisions to quality records. If those connections must be reconstructed manually, you are dependent on institutional memory and tribal knowledge—neither of which are defensible in a submission.

What a unified eQMS and PLM platform changes

Product Lifecycle Management—PLM—is the system of record for design intent: BOMs, CAD models, specifications, design inputs and outputs, verification and validation results. In most organizations, PLM and eQMS are entirely separate systems operated by different teams with different workflows and different data models. The connections between them exist in spreadsheets and shared drives.

When PLM and eQMS share a common data model on a single platform, the relationship between a design decision and its quality implications becomes a first-class concept in the system. A design change does not have to be manually assessed for quality impact—the platform understands what the change touches, which risk controls it may affect, and which quality records reference it. That cascade is deterministic, not dependent on someone remembering to check.

This is the architectural premise behind MANKAIND. The platform is built on the principle that quality management should be a natural output of rigorous engineering—not a parallel documentation effort imposed on top of it. When engineers make design decisions inside the platform, the quality record follows automatically. CAPAs are linked to the design artifacts that generated them. NCRs reference the specifications they violated. Audit trails exist because the work happened in the platform, not because someone filed a form after the fact.

eQMS for medical devices—regulatory requirements you cannot ignore

FDA requires quality system documentation under 21 CFR Part 820, commonly called the Quality System Regulation. The 2024 update aligns 21 CFR Part 820 more closely with ISO 13485:2016, which means manufacturers targeting both US and international markets are increasingly working from a common quality framework.

ISO 13485:2016 specifies requirements for a quality management system where an organization needs to demonstrate its ability to provide medical devices and related services that consistently meet customer and applicable regulatory requirements. Certification to ISO 13485 is required for EU market access under the EU MDR and IVDR, and is accepted by regulators in Canada, Australia, Japan, and Brazil.

Both frameworks share a core expectation: that quality records be complete, traceable, and available on demand. The difference between a manufacturer who meets that expectation confidently and one who scrambles before every audit is almost always a question of platform architecture—not effort or intention.

The right question to ask about your eQMS

The question is not whether your eQMS has the right modules. Most enterprise eQMS platforms check every feature box. The question is whether your eQMS is connected to the engineering decisions that drive quality outcomes—or whether your team is manually maintaining the connection between two separate systems.

If the answer is the latter, you are paying a compounding tax on every design iteration. That tax shows up as delayed submissions, audit findings, and engineering time spent reconstructing records that should have generated themselves.

MANKAIND is built for medical device engineering teams who understand that quality is not a department—it is an output of doing engineering right. When the platform understands your design decisions, your quality system updates itself.